SillaJen, Inc.

KOSDAQ 215600.KQ

SillaJen, Inc. Market Capitalization on January 14, 2025: USD 250.94 M

SillaJen, Inc. Market Capitalization is USD 250.94 M on January 14, 2025, a -55.54% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • SillaJen, Inc. 52-week high Market Capitalization is USD 576.37 M on March 22, 2024, which is 129.69% above the current Market Capitalization.
  • SillaJen, Inc. 52-week low Market Capitalization is USD 227.59 M on December 23, 2024, which is -9.30% below the current Market Capitalization.
  • SillaJen, Inc. average Market Capitalization for the last 52 weeks is USD 374.48 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
KOSDAQ: 215600.KQ

SillaJen, Inc.

CEO Mr. Jaekyung Kim
IPO Date Dec. 6, 2016
Location South Korea
Headquarters O2 Tower
Employees 37
Sector Health Care
Industries
Pharmaceuticals Biotechnology Vaccines
Description

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.

StockViz Staff

January 15, 2025

Any question? Send us an email